Performance of Crohn’s disease Clinical Trial Endpoints based upon Different Cutoffs for Patient Reported Outcomes or Endoscopic Activity: Analysis of EXTEND Data
Author:
Affiliation:
1. Robarts Clinical Trials, Robarts Research Institute and Western University, London, Ontario, Canada
2. University of California San Diego, La Jolla, United States
3. University of Leuven, Leuven, Belgium
4. AbbVie, North Chicago, United States
Publisher
Oxford University Press (OUP)
Subject
Gastroenterology,Immunology and Allergy
Link
http://academic.oup.com/ibdjournal/article-pdf/24/5/932/24798159/izx082.pdf
Reference22 articles.
1. Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions;Peyrin-Biroulet;Clin Gastroenterol Hepatol,2016
2. Results from the 2nd scientific workshop of the ecco. I: impact of mucosal healing on the course of inflammatory bowel disease;Peyrin-Biroulet;J Crohns Colitis,2011
3. Development of a crohn’s disease activity index. National cooperative crohn’s disease study;Best;Gastroenterology,1976
4. Relationships between disease activity and serum and fecal biomarkers in patients with crohn’s disease;Jones;Clin Gastroenterol Hepatol,2008
5. A retrospective analysis: the development of patient reported outcome measures for the assessment of crohn’s disease activity;Khanna;Aliment Pharmacol Ther,2015
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Precise infliximab exposure and pharmacodynamic control to achieve deep remission in paediatric Crohn’s disease (REMODEL-CD): study protocol for a multicentre, open-label, pragmatic clinical trial in the USA;BMJ Open;2024-03
2. Are Radiomic Spleen Features Useful for Assessing the Response to Infliximab in Patients With Crohn's Disease? A Multicenter Study;Clinical and Translational Gastroenterology;2024-02-26
3. To STRIDE or not to STRIDE: a critique of “treat to target” in Crohn´s disease;Expert Review of Gastroenterology & Hepatology;2023-12-02
4. A Systematic Review on Long-Term Efficacy Outcome Measures in Crohn’s Disease Patients;Journal of Crohn's and Colitis;2023-03-13
5. Defining the Failure of Medical Therapy for Inflammatory Bowel Disease in the Era of Advanced Therapies: A Systematic Review;Biomedicines;2023-02-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3